The conclusion that Bamar and Karen differ genetically is not new: a study on CYP2C19*3 allele frequencies, an important gene for the response to barbiturates and malaria drugs [39] and a survey on heme-oxygenase 1 promoter polymorphisms [40] found significant differences between participants of Bamar or Karen origin. Here, CYP2C19 is linked to malaria.